2025-10-17
29 分钟Welcome to Clinical Trial Blazers, a podcast by Park Sale Biotech,
where we dive deep into the journeys of industry leaders who are shaping clinical research and biotech innovation.
I am your host, Alberto Grignolo.
Today on Clinical Trial Blazers, I'm delighted to welcome Dr. Gita Vemuri,
a force in biotech investing in a champion for translating science into real-world impact.
Gita's career sits at the unique intersection of life sciences and venture capital,
and her insight is a rare blend of scientific rigor, strategic vision, and entrepreneurial drive.
Gita is the founder and managing partner of Agent Capital,
a healthcare-focused venture firm that invests across the full spectrum from preclinical to commercial in novel therapeutics that address unmet patient needs.
Throughout her two-decade career, Gita has led and scaled investment programs,
overseen portfolio operations, and steered multiple exits.
She serves or has served on boards of biotech and pharmaceutical companies,
including Covagen, Sintimune, Pixis Oncology, Metagenomi, and TrueNorth Therapeutics.
Gita is my pleasure to see you again and to welcome you today.
Thank you, Alberto.
Would you take me back?
So when you first realized that venture capital and biotech investing would be your path,
was this a carefully planned journey or did serendipity play any role in your choices of career?
Yeah, no. Thank you, Alberto,
for asking this question because I actually think it was more of a carefully planned path,